
Warren found out today that his blood results were such that he is eligible to participate in a clinical Phase I Study of Bactracylin (NSC320846) for solid tumors and lymphomas at NIH. As you may recall he has been in two previous studies there as late as the end of February of this year. He had already exhausted conventional chemotherapy and radiation treatments and the doctors (on the outside) had nothing more to offer him. A Phase I study means that this is the first time this drug will have been used in humans and they are testing for toxicity. It has shown some anti-tumor properties in the lab and in experimental animals. Three people have been approved for this study to date, but they are going to stagger their entry into the protocol, and vary the dosage as well so we don't know when he'll actually be starting this. We'll go in to see the doctors on Thursday this week so maybe we'll get more information then. I almost wish he'd wait to start a few months so that we could go to Florida in April or May while he still feels well enough to go. He of course is anxious to get going on some type of treatment again. We'll see what happens. They've already extended his life over a year and for that we are thankful.
No comments:
Post a Comment